NEW: We've expanded Stock Detail, Screener, and Maps with new data

Stock Detail, Screener:
3, 5, 10-Year Performance
EV/EBITDA, EV/Sales
Dividend Growth (1, 3, 5 Years)
EPS & Sales Growth (3 Years)

Maps:
All from Screener plus:
ROA, ROE, ROIC
Quick & Current Ratios
LT Debt and Debt to Equity Ratios
Gross, Operating, and Net Margins

ICLR

Icon Plc

Jul 11 • 04:00PM ET

150.52

Dollar change -1.55
Percentage change -1.02	%

Healthcare • Diagnostics & Research • Ireland • NASD

Peers: PFE MRK JNJ ABBV LLY BMY AMGN REGN GILD VRTX

| Held by: SPDW BBH DSTL DFAT VT RUNN TMFG TCAF FNDF QQQJ

Scroll to Statements

Index	-	P/E	16.38	EPS (ttm)	9.19	Insider Own	0.65%	Shs Outstand	80.76M	Perf Week	0.28%
Market Cap	12.16B	Forward P/E	10.60	EPS next Y	14.20	Insider Trans	0.00%	Shs Float	80.24M	Perf Month	4.00%
Enterprise Value	15.19B	PEG	4.59	EPS next Q	3.19	Inst Own	88.16%	Short Float	2.59%	Perf Quarter	-3.20%
Income	758.19M	P/S	1.48	EPS this Y	-5.42%	Inst Trans	-7.70%	Short Ratio	1.36	Perf Half Y	-32.37%
Sales	8.19B	P/B	1.26	EPS next Y	7.21%	ROA	4.49%	Short Interest	2.08M	Perf YTD	-28.22%
Book/sh	119.56	P/C	23.08	EPS next 5Y	3.57%	ROE	8.01%	52W High	347.72 -56.71%	Perf Year	-53.54%
Cash/sh	6.52	P/FCF	11.66	EPS past 3/5Y	61.03% 6.54%	ROIC	5.82%	52W Low	125.10 20.32%	Perf 3Y	-31.49%
Dividend Est.	-	EV/EBITDA	8.81	Sales past 3/5Y	14.75% 24.17%	Gross Margin	23.69%	Volatility	3.33% 3.38%	Perf 5Y	-11.18%
Dividend TTM	-	EV/Sales	1.85	EPS Y/Y TTM	11.47%	Oper. Margin	14.54%	ATR (14)	5.15	Perf 10Y	123.32%
Dividend Ex-Date	-	Quick Ratio	1.27	Sales Y/Y TTM	-0.48%	Profit Margin	9.25%	RSI (14)	57.89	Recom	1.67
Dividend Gr. 3/5Y	- -	Current Ratio	1.27	EPS Q/Q	-15.39%	SMA20	1.97%	Beta	1.16	Target Price	175.47
Payout	0.00%	Debt/Eq	0.37	Sales Q/Q	-4.26%	SMA50	7.04%	Rel Volume	0.66	Prev Close	152.07
Employees	41900	LT Debt/Eq	0.37	Earnings	Jul 23 AMC	SMA200	-21.42%	Avg Volume	1.53M	Price	150.52
IPO	May 15, 1998	Option/Short	Yes / Yes	EPS/Sales Surpr.	2.73% -0.32%	Trades		Volume	1,009,179	Change	-1.02%

Date	Action	Analyst	Rating Change	Price Target Change
Apr-29-25	Downgrade	JP Morgan	Overweight → Neutral	$150
Apr-14-25	Downgrade	TD Cowen	Buy → Hold	$157
Apr-10-25	Downgrade	Barclays	Overweight → Equal Weight	$165
Mar-21-25	Downgrade	Goldman	Buy → Neutral	$250 → $200
Jan-07-25	Initiated	RBC Capital Mkts	Outperform	$263
Oct-24-24	Downgrade	Robert W. Baird	Outperform → Neutral	$340
Oct-14-24	Initiated	Redburn Atlantic	Neutral
Sep-18-24	Initiated	Leerink Partners	Outperform	$379
Jun-06-24	Initiated	Goldman	Buy	$370
Dec-15-23	Initiated	Truist	Buy	$357
Sep-13-23	Initiated	TD Cowen	Outperform	$306
Jan-17-23	Upgrade	Barclays	Equal Weight → Overweight	$215 → $260
Jan-13-23	Upgrade	Barclays	Equal Weight → Overweight
Nov-09-22	Upgrade	BofA Securities	Neutral → Buy	$265 → $260
Sep-07-22	Initiated	UBS	Buy	$270
Aug-25-22	Initiated	Credit Suisse	Neutral	$260
May-24-22	Initiated	Guggenheim	Buy	$285
Apr-25-22	Downgrade	Wells Fargo	Overweight → Equal Weight	$250
Apr-12-22	Upgrade	Deutsche Bank	Hold → Buy	$234 → $310
Sep-27-21	Upgrade	JP Morgan	Neutral → Overweight	$230 → $320

Show Previous Ratings

Jul-07-25 07:15AM	ICON and Its Employees Recognised as Clinical Research Industry Leaders, and for Innovation and Progress in Sustainability (Business Wire)
07:06AM	Clearbridge Large Cap Growth Strategy Sold Its Stake in ICON Public Limited Company (ICLR) (Insider Monkey)
Jul-03-25 10:13AM	Will ICON PLC (ICLR) Benefit from R&D Spending? (Insider Monkey)
Jun-27-25 09:15AM	Tempus AI's Data Business Keeps Scaling Up: Can the Growth Pace Last? (Zacks)
Jun-23-25 06:30AM	ICON plc Schedules Second Quarter 2025 Earnings Conference Call (Business Wire)
10:23AM	Loading…
Jun-02-25 10:23AM	Here's Why You Should Retain ICLR Stock in Your Portfolio Now (Zacks)
04:12AM	ICLR Shareholders Have the Right to Lead the ICON Public Limited Company Securities Lawsuit - Contact the DJS Law Group to Discuss Your Rights - ICLR (PR Newswire)
May-30-25 11:31AM	Icon PLC (ICLR) Down 9.7% Since Last Earnings Report: Can It Rebound? (Zacks)
May-27-25 08:30AM	ICON plc to Present at the William Blair 45th Annual Growth Stock Conference (Business Wire)
May-19-25 04:15PM	ICON releases its ICON Cares 2024 Report (Business Wire)
May-14-25 07:52AM	ICON Public Limited Company (ICLR): Among Small-Cap Healthcare Stocks Hedge Funds Are Buying (Insider Monkey) -5.88%
May-09-25 03:13AM	ICON Public Limited Company (ICLR): Among Steven Cohen's Mid-Cap Stock Picks with Huge Upside Potential (Insider Monkey)
May-07-25 12:55PM	ICON Public Limited Company (ICLR): A Bull Case Theory (Insider Monkey)
07:27AM	Global ICON survey shows need for more efficient obesity clinical trial design to realise full potential of next-gen multi-indication therapies (Business Wire)
May-02-25 09:00PM	LRT Capital Management April 2025 Investor Update (Seeking Alpha)
03:01AM	Loading…
03:01AM	Icon PLC (ICLR) Q1 2025 Earnings Call Highlights: Navigating Challenges with Strategic Initiatives (GuruFocus.com)
02:42AM	ICON Public Limited Company (ICLR) Q1 2025 Earnings Call Transcript (Seeking Alpha)
May-01-25 06:43PM	Analyst Report: ICON Public Limited Company (Morningstar Research)
09:16AM	ICON's Q1 Earnings Surpass Estimates, Revenues Lag, Stock Down (Zacks)
Apr-30-25 06:15PM	Icon PLC (ICLR) Beats Q1 Earnings Estimates (Zacks)
05:23PM	Is ICON Public Limited (ICLR) One of the Oversold Global Stocks to Buy According to Hedge Funds? (Insider Monkey)
04:15PM	ICON Reports First Quarter 2025 Results (Business Wire)
Apr-29-25 09:12AM	What to Expect From These 3 MedTech Stocks This Earnings Season? (Zacks)
Apr-27-25 04:19PM	ICON Public Limited Company (ICLR): Among the Oversold Growth Stocks to Buy Now (Insider Monkey)
Apr-24-25 10:01AM	Analysts Estimate Organon (OGN) to Report a Decline in Earnings: What to Look Out for (Zacks)
Apr-23-25 10:01AM	Analysts Estimate Icon PLC (ICLR) to Report a Decline in Earnings: What to Look Out for (Zacks)
Apr-22-25 07:20AM	ClearBridge International Value Strategy Q1 2025 Commentary (Seeking Alpha)
Apr-10-25 09:26AM	What Makes Icon PLC (ICLR) an Investment Bet? (Insider Monkey) -8.26%
08:55AM	GreensKeeper Q1 2025 Portfolio Update (Seeking Alpha)
Apr-09-25 07:10AM	GreensKeeper Value Fund Q1 2025 Letter (Seeking Alpha) +9.12%
06:58AM	Loading…
Apr-08-25 06:58AM	ClearBridge Mid Cap Portfolios Q4 2024 Commentary (Seeking Alpha) -5.52%
Apr-03-25 06:13PM	Anne Whitaker Appointed as Non-Executive Director (GlobeNewswire) -6.04%
12:35PM	Is ICON Public Limited Company (ICLR) The Best Beaten Down Stock to Buy According to Analysts? (Insider Monkey)
10:03AM	LVS Advisory Sold Icon Plc (ICLR) After Identifying Flaws in its Investment Thesis (Insider Monkey)
Apr-02-25 08:00AM	Icon Plc: The Sale Was Well-Timed (Seeking Alpha)
06:00AM	LVS Advisory Q1 2025 Letter (Seeking Alpha)
Mar-31-25 06:30AM	ICON plc Schedules First Quarter 2025 Earnings Conference Call (Business Wire)
03:15AM	John Hancock International Growth Fund Q4 2024 Commentary (Seeking Alpha)
Mar-28-25 05:45AM	Shareholders of ICON Public Limited Company Should Contact Levi & Korsinsky Before April 11, 2025 to Discuss Your Rights - ICLR (PR Newswire)
Mar-27-25 11:50PM	ClearBridge Mid Cap Growth Portfolios Q4 2024 Commentary (SeekingAlpha)
Mar-25-25 10:45AM	Allspring Small Company Growth Fund Q4 2024 Commentary (SeekingAlpha)
Mar-24-25 10:46PM	Wasatch Global Select Fund Q4 2024 Commentary (SeekingAlpha)
10:15PM	Wasatch International Select Fund Q4 2024 Commentary (SeekingAlpha)
05:09PM	BetterInvesting Magazine Update on Lowe's Cos. (NYSE: LOW) and ICON PLC (NASDAQ: ICLR) (PR Newswire)
12:34PM	Is ICON Public Limited Company (ICLR) the Best Diagnostics Stock to Invest in Right Now? (InsiderMonkey)
Mar-23-25 06:05PM	Icon Plc (ICLR) Leverages AI-Powered Medidata Platform to Optimize Clinical Trials (InsiderMonkey)
Mar-21-25 11:30AM	Why Is Icon PLC (ICLR) Down 8.9% Since Last Earnings Report? (Zacks)
Mar-20-25 11:15AM	Lazard International Strategic Equity Portfolio Q4 2024 Commentary (SeekingAlpha)
05:35AM	Lazard International Equity Select Portfolio Q4 2024 Commentary (SeekingAlpha)
05:15AM	Lazard International Equity Portfolio Q4 2024 Commentary (SeekingAlpha)
04:00AM	ICON Becomes the First Large Clinical Research Organization to Fully Integrate Medidata Clinical Data Studio, Streamlining Data Management and Review (Business Wire)
Mar-19-25 09:05AM	ICON Public Limited Company (ICLR) Slid on Disappointing Earnings (Insider Monkey)
Mar-18-25 09:37AM	Does ICON Public Limited Company (ICLR) have a Favorable Long-Term Outlook? (Insider Monkey)
05:45AM	ICON Public Limited Company Sued for Securities Law Violations - Contact Levi & Korsinsky Before April 11, 2025 to Discuss Your Rights - ICLR (PR Newswire)
Mar-12-25 07:45AM	What makes ICON Public Limited Company (ICLR) an Attractive Investment? (Insider Monkey)
Mar-11-25 06:37PM	Analyst Report: ICON Public Limited Company (Morningstar Research)
Mar-10-25 10:25AM	Do Options Traders Know Something About ICON (ICLR) Stock We Don't? (Zacks)
Mar-06-25 06:37PM	ICON Public Limited Company (ICLR): A Bull Case Theory (Insider Monkey)
Mar-05-25 07:30AM	ICON plc to Present at Upcoming Investor Conferences (Business Wire)
Feb-26-25 08:56PM	Robbins LLP Reminds ICON PLC (ICLR) Investors With Large Losses to Contact the Firm to Learn How They Can Recover for Their Losses (PR Newswire)
Feb-24-25 06:30PM	Kessler Topaz Meltzer & Check, LLP Encourages ICON Public Limited Company Investors with Losses to Contact the Firm (PR Newswire)
Feb-21-25 08:56AM	Analyst Report: ICON Public Limited Company (Morningstar Research)
02:03AM	Icon PLC (ICLR) Q4 2024 Earnings Call Highlights: Navigating Challenges with Strategic Growth (GuruFocus.com)
Feb-19-25 06:05PM	Icon PLC (ICLR) Q4 Earnings and Revenues Top Estimates (Zacks) +5.50%
04:15PM	ICON Reports Fourth Quarter and Full Year 2024 Results (Business Wire)
Feb-14-25 05:45AM	Contact Levi & Korsinsky by April 11, 2025 Deadline to Join Class Action Against ICON Public Limited Company(ICLR) (PR Newswire)
Feb-12-25 10:00AM	Earnings Preview: Icon PLC (ICLR) Q4 Earnings Expected to Decline (Zacks)
Jan-31-25 10:26AM	Heres Why Baron Small Cap Fund is Holding ICON Public Limited Company (ICLR) (Insider Monkey)
04:04AM	ICON plc (ICLR): Revolutionizing Clinical Trials with AI Innovations (Insider Monkey)
Jan-30-25 07:50AM	ICON Portfolio of AI Tools Drives Clinical Trial Efficiencies (Business Wire)
Jan-29-25 07:15AM	ICON plc Schedules Fourth Quarter and Full Year 2024 Earnings Conference Call (Business Wire)
Jan-15-25 08:11AM	Icon sees FY25 adjusted EPS $13.00-$15.00, consensus $14.93 (TipRanks)
Jan-14-25 08:00AM	ICON Issues Financial Guidance for Full Year 2025 (Business Wire) -8.14%
Jan-13-25 08:56AM	What Makes ICON Public Limited Company (ICLR) a High-Quality Contender in the CRO Industry? (Insider Monkey)
Jan-08-25 08:32AM	What Makes ICON Public Limited Company (ICLR) a Prospective Investment? (Insider Monkey)
07:00AM	Biomarker and Trial Optimisation Needed to Drive RandD Progress in Alzheimers and Related Disorders ICON Survey (Business Wire)
Jan-07-25 08:15AM	Icon price target lowered to $290 from $300 at Citi (TipRanks)
06:00AM	ICON plc to Present at the 43rd Annual J.P. Morgan Healthcare Conference (Business Wire)
Dec-31-24 08:28AM	ICON Public Limited Company (ICLR) Slid on Drop in Biotechnology Funding (Insider Monkey)
Dec-23-24 07:15AM	ICON and Its Employees Celebrated for Excellence in the Field of Clinical Research (Business Wire)
Dec-18-24 07:00AM	ICON Announces Appointment of Chief Operating Officer (Business Wire)
Dec-09-24 08:40AM	ICON Public Limited Company (ICLR) Fell on Reduced Guidance (Insider Monkey)
Dec-05-24 12:12PM	ICON Public Limited Company (ICLR) Fell Along with Peers (Insider Monkey)
07:15AM	ICON Survey Highlights Sustained Investment in AI and Digital RandD Innovation, Tempered by Siloed Adoption (Business Wire)
07:15AM	ICON Survey Highlights Sustained Investment in AI and Digital R&D Innovation, Tempered by Siloed Adoption (Business Wire)
Nov-22-24 11:31AM	Icon PLC (ICLR) Down 4.1% Since Last Earnings Report: Can It Rebound? (Zacks)
Nov-21-24 10:11AM	Should You Retain Your Conviction in Icon Plc (ICLR)? (Insider Monkey)
04:55AM	Baird cuts Icon target, names Bullish Fresh Pick (TipRanks)
Nov-15-24 12:06PM	ICON Public Limited Company (ICLR): Among 12 High Growth Large Cap Stocks to Buy Now (Insider Monkey) -5.19%
10:36AM	ICON Shareholders are Encouraged to Reach Out to Johnson Fistel for More Information About Potentially Recovering Their Losses (PR Newswire)
Nov-13-24 08:00AM	ICON plc to Present at the Jefferies London Healthcare Conference (Business Wire)
Nov-11-24 10:38AM	ICON Shareholders are Encouraged to Reach Out to Johnson Fistel for More Information About Potentially Recovering Their Losses (GlobeNewswire)
Oct-25-24 12:21PM	ICON's $650 Million Power Play: Can This Bold Move Reverse a 21% Stock Plunge? (GuruFocus.com)
03:07AM	Icon PLC (ICLR) Q3 2024 Earnings Call Highlights: Navigating Challenges with Strategic ... (GuruFocus.com)
Oct-24-24 06:23PM	Analyst Report: ICON Public Limited Company (Morningstar Research) -21.03%
Oct-23-24 05:55PM	Icon PLC (ICLR) Lags Q3 Earnings and Revenue Estimates (Zacks)
04:15PM	ICON Reports Third Quarter 2024 Results (Business Wire)
Oct-16-24 10:01AM	Icon PLC (ICLR) Earnings Expected to Grow: Should You Buy? (Zacks)
Sep-27-24 06:00AM	ICON plc Schedules Third Quarter 2024 Earnings Conference Call (Business Wire)
Sep-25-24 06:20PM	Analyst Report: ICON Public Limited Company (Morningstar Research)

ICON plc operates as a clinical research organization, which engages in the provision of outsourced development services to the pharmaceutical, biotechnology, and medical device industries. It specializes in the development, management and analysis of programs that support clinical development. It operates through the following geographical segments: Ireland, Rest of Europe, U.S. and Other. The company was founded by John Climax and Ronan Lambe in June 1990 and is headquartered in Dublin, Ireland.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	SEC Form 4
RONAN MARTIN MURPHY	Officer	May 23 '25	Proposed Sale	126.90	334	42,384	May 23 04:38 PM
EUGENE PACELLI MCCAGUE	Officer	May 23 '25	Proposed Sale	126.90	334	42,384	May 23 04:35 PM
LINDA SUE GRAIS	Officer	May 23 '25	Proposed Sale	126.90	334	42,384	May 23 04:32 PM
JOHN CLIMAX	Officer	May 23 '25	Proposed Sale	126.90	334	42,384	May 23 04:27 PM
JULIE ANN ONEILL	Officer	May 23 '25	Proposed Sale	126.90	363	46,065	May 23 04:25 PM
CIARAN MURRAY	Officer	May 23 '25	Proposed Sale	126.90	494	62,688	May 23 04:23 PM
RONAN MARTIN MURPHY	Officer	May 19 '25	Proposed Sale	130.04	1,539	200,131	May 19 04:58 PM
JOHN CLIMAX	Officer	May 19 '25	Proposed Sale	130.04	7,693	1,000,422	May 19 04:30 PM
Dr. John Climax	Director	May 06 '25	Proposed Sale	143.02	140,000	20,022,800	May 06 05:00 PM
RONAN MARTIN MURPHY	Officer	Mar 17 '25	Proposed Sale	187.07	1,540	288,082	Mar 17 04:33 PM
THOMAS NOEL O LEARY	Officer	Mar 04 '25	Proposed Sale	182.43	796	145,214	Mar 04 05:24 PM
DIARMAID CUNNINGHAM	Officer	Mar 04 '25	Proposed Sale	182.43	1,185	216,180	Mar 04 05:23 PM
BARRY EDWARD BALFE	Officer	Mar 04 '25	Proposed Sale	182.43	1,216	221,835	Mar 04 05:20 PM
STEPHEN CUTLER	Officer	Mar 04 '25	Proposed Sale	182.43	5,496	1,002,635	Mar 04 05:18 PM
Poplar Limited DNE	Director	Dec 05 '24	Proposed Sale	214.50	17,500	3,753,750	Dec 05 05:35 PM
UTE BERGER	Officer	Aug 26 '24	Proposed Sale	320.82	11,827	3,794,380	Aug 26 04:01 PM
DIARMAID CUNNINGHAM	Officer	Jul 30 '24	Proposed Sale	330.42	5,969	1,972,304	Jul 30 05:26 PM
BRENDAN BRENNAN	Officer	Jul 29 '24	Proposed Sale	325.99	26,064	8,496,637	Jul 29 05:13 PM
THOMAS NOEL O' LEARY	Officer	Jul 29 '24	Proposed Sale	324.32	6,360	2,062,669	Jul 29 04:15 PM

open in yahoo | open in reuters | open in marketwatch | open in google | open in EDGAR

ICLR

Icon Plc

Upgrade your FINVIZ experience